Sign in

CIK 0000944809

  • Accelerated filer

OPKO HEALTH, INC.

Sign in to watch
Ticker
OPK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
752402409
Phone
+1 305-575-4181
Business address
4400 BISCAYNE BLVD., MIAMI, FL, 33137
Former names
EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
  1. 4 Grant or award Sr. Vice President, CFO acquired 437,500 shares (grant or award)
  2. 4 Grant or award Executive VP-Administration acquired 437,500 shares (grant or award)
  3. 4 Grant or award Vice Chairman and President acquired 500,000 shares (grant or award)
  4. 4 Grant or award Chief Innovation Officer acquired 437,500 shares (grant or award)
  5. 4 Open-market sale 10% owner sold 150,000 shares at an average $32.98 ($4,946,935)
  6. 4 Open-market sale 10% owner sold 25,000 shares at $32.93 ($823,188)
  7. 4 Open-market sale 10% owner sold 36,118 shares at $28.24 ($1,020,016)
  8. 4 Planned sale 10% owner sold 89,082 shares at an average $27.58 ($2,457,286)
  9. 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $1.27 ($126,937)
  10. 4 Open-market buy CEO & Chairman bought 163,997 shares at $1.29 ($211,195)
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Open-market buy CEO & Chairman bought 500,000 shares at $0.87 ($437,100)
  18. 4 Open-market buy CEO & Chairman bought 500,000 shares at $0.89 ($444,300)
  19. 4 Open-market buy CEO & Chairman bought 500,000 shares at $0.93 ($463,750)
  20. 4 Open-market buy CEO & Chairman bought 600,000 shares at $0.93 ($559,380)

Page 4 of 106 · 2,118 filings